[Pecularities of atherosclerosis developed after chlamidial infection and behaviour of some hematological and biochemical parameters].

The aim of our studies was to create diagnostically informative criteria of hematologic and biochemical analyses and their combinations as well as to establish relation between Chlamidia Pneumoniae A and atherosclerosis. This is to be done for the purpose of establishing the entire pathogenesis carotid and coronary atherosclerosis and inflammation. The investigation of Chlamidia Pneumoniae infection in proved to be a possible risk factor for the carotid atherosclerosis developed in adults that makes the course of atherosclerosis heavier.

[Cytokines and smoking in the cases of reactive arthritis during urogenital chlamydiosis].

The aim of the work was the determination of blood serum cytokines level and identification of possible association of the latter with smoking in the case of reactive arthritis (ReA) developed on the background of urogenital chlamydiosis. 74 patients with ReA were tested. 19 patients had acute ReA (disease duration not exceeding 6 months from manifestation of chlamydiosis) and 55 - chronic ReA (disease duration exceeding 6 months from manifestation of chlamydiosis).

[Possibilities of colposcopy in the diagnostics of cervical Chlamydia-mycoplasmatic infections (population prospective study)].

Possibilities of colposcopy in the diagnostics of cervical chlamydia-mycoplastic infections are less investigated. The aim of given work was the study of this problem. Colposcopic examination was performed in 952 women (age - from 16 to 67) asked to clinics for examination and more precise definition of diagnosis because of different complaints.

[Homocysteine as risk marker of cardiovascular disease].

Basic research has demonstrated that homocysteine enhances both arteriosclerosis and thrombosis - the principal cause of CVD. Although studies demonstrate that patients with elevated homocysteine levels have small to moderate increased risk of CVD it remains unclear whether lowering plasma homocysteine levels will decrease risks of CVD. The study was aimed to detect reliability of homocysteine lowering on risk of CVD.